As of 11:37 AM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
| Age | Total Calculated Compensation | This person is connected to 123 board members in 7 different organizations across 11 different industries.
See Board Relationships |
| 51 | $25,000
As of Fiscal Year 2012 |
Background*
Mr. Timothy M. Mayleben, Tim has been Chief Executive Officer and President of Esperion Therapeutics, Inc. since January 4, 2013. Mr. Mayleben serves as the President of ElMa Advisors, LLC. He has been the Chief Operating Officer and Executive Vice President of Nighthawk Radiology Services, LLC since January 2007. He served as the Chief Executive Officer and President of Aastrom Biosciences Inc. since December 14, 2009. He has nearly 20 years of experience with entrepreneurial ... companies and is an active angel investor in Michigan life sciences companies. He served as President of NightHawk Radiology Holdings, Inc. since July 25, 2007 and served as its Chief Operating Officer and Executive Vice President from January 8, 2007 to July 25, 2007. Mr. Mayleben served as Chief Executive Officer and President of Alba Therapeutics Corporation. He served as Chief Financial Officer of Aastrom Biosciences Inc. from December 14, 2009 to June 7, 2010. Mr. Mayleben served as a Consultant with ElMa and has been advising life science and health care companies since 2004. He served as the Chief Operating Officer of Esperion Therapeutics Inc. from 2002 to 2004 and served as its Chief Financial Officer since January 1999. He joined Esperion in 1998 and was responsible for raising more than $200 million in venture capital and institutional equity funding and later negotiated the acquisition of Esperion by Pfizer in December 2003. He also served as the Senior Vice President of Operations and Finance at Esperion from January 2002 to April 2002 and as the Vice President of Finance from January 1999 to January 2002. Mr. Mayleben served as the Director of Business Development for Engineering Animation Inc. from September 1998 to December 1998. From July 1997 to September 1998, he served as the Chief Operating Officer and Chief Financial Officer of Transom Technologies Inc. He raised capital and co-led the negotiations for the sale of Transom to EDS. From September 1990 to July 1997, he served in various managerial positions including as the Director of Operations of Applied Intelligent Systems Inc. Mr. Mayleben served as a Manager with the Enterprise Group of Arthur Andersen & Co. He started his professional career with an international public accounting firm in 1984. Mr. Mayleben serves as a Director for several private life science companies. He serves as a Director of Marinus Pharmaceuticals, Inc., Lycera Corporation, Intelliject, Inc. and Esperion Therapeutics, Inc. Mr. Mayleben serves as a Member of the Advisory Board at The Wolverine Venture Fund, L.P. He has been a Director of Aksys Ltd. since June 23, 2006. Mr. Mayleben has been a Director of Nighthawk Radiology Services, LLC since 2005. Mr. Mayleben served as a Director of Aastrom Biosciences, Inc. since June 20, 2005. He served as a Director of Rubicon Genomics Inc. He served as a Director of Nighthawk Radiology Holdings Inc. since March 2005 and Advanced ICU Care, Inc. since November 2006. He serves as an Advisor to several biotechnology companies in the Ann Arbor area. Mr. Mayleben also served as a Member of the Board of Directors of Computer Challenge Inc. He served as a Member of Advisory Board at Alba Therapeutics Corporation. He is also an active angel investor in Michigan life sciences companies. Mr. Mayleben has an M.B.A. with distinction from the J.L. Kellogg Graduate School of Management at Northwestern University and a B.B.A. from the University of Michigan Ross School of Business.
Corporate Headquarters*
Dominos Farms Lobby K
Ann Arbor, Michigan 48105
United States
Phone: 734-418-4400
Fax: 734-665-0485
Board Members Memberships*
Former Director Director Director Director 2005-N/A Former Director 2005-N/A Former President and Director 2005-Present Chief Operating Officer, Executive Vice President and Director 2006-Present Director and Chairman of Audit Committee 2006-N/A Former Director 2010-Present Chief Executive Officer, President and Director
Education*
MBA Northwestern University BBA Ross School of Business, University of Michigan
Other Affiliations*
|
Annual Compensation*
| Salary | $25,000 | | Total Annual Compensation | $25,000 |
Stock Options*
| Exercisable Options | 146,597 | | Unexercisable Options | 51,549 | | Total Number of Options | 198,146 |
Total Compensation*
| Total Annual Cash Compensation | $25,000 | | Total Short Term Compensation | $25,000 | | Total Calculated Compensation | $25,000 |
|
*Data is at least as current as the most recent Definitive Proxy.
Stock Quotes
Market data is delayed at least 15 minutes.
| Recently Viewed |
|
ASTM:US
|
$0.57 USD |
+0.0015 |
 |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Sponsored Financial Commentaries
Sponsored Links
